A detailed history of Caption Management, LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Caption Management, LLC holds 40,000 shares of ARDX stock, worth $223,600. This represents 0.0% of its overall portfolio holdings.

Number of Shares
40,000
Holding current value
$223,600
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$3.29 - $6.64 $172,725 - $348,600
52,500 New
52,500 $325,000
Q1 2021

May 17, 2021

SELL
$6.1 - $7.69 $115,900 - $146,110
-19,000 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$5.05 - $7.1 $95,950 - $134,900
19,000 New
19,000 $123,000

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $864M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.